Drug Benefit List 2010
08:00 ANTI-INFECTIVE AGENTS
08:08.00 ANTHELMINTICS
MEBENDAZOLE
- 100mg Tablet
- 556734 VERMOX JNO
PYRANTEL PAMOATE
- 50mg/mL Suspension
- 1944355 COMBANTRIN PFI
- 125mg Tablet
- 1944363 COMBANTRIN PFI
08:12.06 CEPHALOSPORINS
CEFACLOR
- 250mg Capsule
- 2230263 APO-CEFACLOR APX
- 465186 CECLOR PHH
- 2177633 DOM-CEFACLOR DPC
- 2231432 NU-CEFACLOR NXP
- 2238200 PDL-CEFACLOR PDL
- 2237729 SCHEIN-CEFACLOR SCN
- 500mg Capsule
- 2230264 APO-CEFACLOR APX
- 465194 CECLOR PHH
- 2177641 DOM-CEFACLOR DPC
- 2231433 NU-CEFACLOR NXP
- 2238201 PDL-CEFACLOR PDL
- 2237730 SCHEIN-CEFACLOR SCN
- 25mg/mL Suspension
- 465208 CECLOR PHH
- 2177668 DOM-CEFACLOR DPC
- 2238202 PDL-CEFACLOR PDL
- 50mg/mL Suspension
- 465216 CECLOR PHH
- 2177676 DOM-CEFACLOR DPC
- 2238203 PDL-CEFACLOR PDL
- 75mg/mL Suspension
- 2237502 APO-CEFACLOR APX
- 832804 CECLOR BID PHH
- 2177684 DOM-CEFACLOR DPC
- 2238204 PDL-CEFACLOR PDL
CEFADROXIL
- 500mg Capsule
- 2240774 APO-CEFADROXIL APX
- 2235134 NOVO-CEFADROXIL NOP
- 2311062 PRO-CEFADROXIL PDL
CEFIXIME
- 20mg/mL Suspension
- 868965 SUPRAX SAC
- 400mg Tablet
- 868981 SUPRAX SAC
CEFPROZIL
- 25mg/mL Suspension
- 2293943 APO-CEFPROZIL APX
- 2163675 CEFZIL BMS
- 2303426 SANDOZ CEFPROZIL SDZ
- 50mg/mL Suspension
- 2293951 APO-CEFPROZIL APX
- 2163683 CEFZIL BMS
- 2293579 RAN-CEFPROZIL RBY
- 2303434 SANDOZ CEFPROZIL SDZ
- 250mg Tablet
- 2292998 APO-CEFPROZIL APX
- 2163659 CEFZIL BMS
- 2293528 RAN-CEFPROZIL RBY
- 2302179 SANDOZ CEFPROZIL SDZ
- 500mg Tablet
- 2293005 APO-CEFPROZIL APX
- 2163667 CEFZIL BMS
- 2293536 RAN-CEFPROZIL RBY
- 2302187 SANDOZ CEFPROZIL SDZ
CEFPROZIL MONOHYDRATE
- 125MG/5ML Oral Liquid
- 2329204 RAN-CEFPROZIL RBY
- 2329204 RAN-CEFPROZIL RBY
CEFUROXIME AXETIL
- 25mg/mL Suspension
- 2212307 CEFTIN GSK
- 250mg Tablet
- 2244393 APO-CEFUROXIME APX
- 2212277 CEFTIN GSK
- 2242656 RATIO-CEFUROXIME RPH
- 500mg Tablet
- 2244394 APO-CEFUROXIME APX
- 2212285 CEFTIN GSK
- 2311453 PRO-CEFUROXIME PDL
- 2242657 RATIO-CEFUROXIME RPH
CEPHALEXIN
- 250mg Capsule
- 342084 NOVO-LEXIN NOP
- 500mg Capsule
- 342114 NOVO-LEXIN NOP
- 25mg/mL Suspension
- 2177862 DOM-CEPHALEXIN DPC
- 342106 NOVO-LEXIN NOP
- 50mg/mL Suspension
- 2177870 DOM-CEPHALEXIN DPC
- 342092 NOVO-LEXIN NOP
CEPHALEXIN
- 250mg Tablet
- 768723 APO-CEPHALEX APX
- 2177846 DOM-CEPHALEXIN DPC
- 583413 NOVO-LEXIN NOP
- 865877 NU-CEPHALEX NXP
- 828858 PDL-CEPHALEXIN PDL
- 2177781 PMS-CEPHALEXIN PMS
- 500mg Tablet
- 768715 APO-CEPHALEX APX
- 2177854 DOM-CEPHALEXIN DPC
- 583421 NOVO-LEXIN NOP
- 865885 NU-CEPHALEX NXP
- 828866 PDL-CEPHALEXIN PDL
- 2177803 PMS-CEPHALEXIN PMS
08:12.12 MACROLIDES
AZITHROMYCIN
- 100MG/5ML Oral Liquid
- 2332388 SANDOZ-AZITHROMYCIN SDZ
- 200MG/5ML Oral Liquid
- 2332396 SANDOZ-AZITHROMYCIN SDZ
- 20mg/mL Suspension
- 2315157 NOVO-AZITHROMYCIN NOP
- 2274388 PMS-AZITHROMYCIN PMS
- 2223716 ZITHROMAX PFI
- 40mg/mL Suspension
- 2315165 NOVO-AZITHROMYCIN NOP
- 2274396 PMS-AZITHROMYCIN PMS
- 2223724 ZITHROMAX PFI
- 250mg Tablet
- 2247423 APO-AZITHROMYCIN APX
- 2255340 CO AZITHROMYCIN COB
- 2278359 GEN-AZITHROMYCIN GEN
- 2267845 NOVO-AZITHROMYCIN NOP
- 2278588 PHL-AZITHROMYCIN PMI
- 2261634 PMS-AZITHROMYCIN PMS
- 2310600 PRO-AZITHROMYCIN PDL
- 2275287 RATIO-AZITHROMYCIN RPH
- 2275309 RIVA-AZITHROMYCIN RIV
- 2265826 SANDOZ-AZITHROMYCIN SDZ
- 2212021 ZITHROMAX PFI
- 600mg Tablet
- 2256088 CO AZITHROMYCIN COB
- 2261642 PMS-AZITHROMYCIN PMS
- 2275317 RIVA-AZITHROMYCIN RIV
- 2231143 ZITHROMAX PFI
CLARITHROMYCIN
- 500mg Extended Release Tablet
- 2244756 BIAXIN XL ABB
CLARITHROMYCIN
- 250mg Film Coated Tablet
- 2274744 APO-CLARITHROMYCIN APX
- 1984853 BIAXIN ABB
- 2248856 GEN-CLARITHROMYCIN GEN
- 2247573 PMS-CLARITHROMYCIN PMS
- 2247818 RATIO-CLARITHROMYCIN RPH
- 2266539 SANDOZ-CLARITHROMYCIN RHO
- 500mg Film Coated Tablet
- 2266547 SANDOZ-CLARITHROMYCIN RHO
- 500mg Film Coated Tablet
- 2274752 APO-CLARITHROMYCIN APX
- 2126710 BIAXIN ABB
- 2248857 GEN-CLARITHROMYCIN GEN
- 2247574 PMS-CLARITHROMYCIN PMS
- 2247819 RATIO-CLARITHROMYCIN RPH
- 25mg/mL Suspension
- 2146908 BIAXIN ABB
- 50mg/mL Suspension
- 2244641 BIAXIN ABB
ERYTHROMYCIN
- 250mg Enteric Coated Capsule
- 726672 APO-ERYTHRO APX
- 607142 ERYC PFI
- 333mg Enteric Coated Capsule
- 1925938 APO-ERYTHRO APX
- 333mg Enteric Coated Tablet
- 873454 ERYC PFI
- 250mg Tablet
- 682020 APO-ERYTHRO BASE APX
ERYTHROMYCIN ESTOLATE
- 50mg/mL Suspension
- 262595 NOVO-RYTHRO ESTOLATE NOP
ERYTHROMYCIN ETHYLSUCCINATE
- 40mg/mL Suspension
- 605859 NOVO-RYTHRO ETHYLSUCCINATE NOP
- 80mg/mL Suspension
- 652318 NOVO-RYTHRO ETHYLSUCCINATE NOP
- 600mg Tablet
- 637416 APO-ERYTHRO-S APX
- 583782 EES-600 ABB
- 704377 ERYTHRO-ES PDL
ERYTHROMYCIN STEARATE
- 250mg Tablet
- 545678 APO-ERYTHRO-S APX
- 563854 ERYTHROMYCIN PDL
- 2051850 NU-ERYTHROMYCIN S NXP
- 500mg Tablet
- 688568 APO-ERYTHRO S APX
- 704393 ERYTHRO PDL
08:12.16 PENICILLINS
AMOXICILLIN
- 250mg Capsule
- 628115 APO-AMOXI APX
- 2238171 GEN-AMOXICILLIN GEN
- 2239761 MED-AMOXICILLIN MEC
- 406724 NOVAMOXIN NOP
- 865567 NU-AMOXI NXP
- 2229584 PENTA-AMOXICILLIN PEN
- 2230243 PMS-AMOXICILLIN PMS
- 644307 PRO-AMOX PDL
- 2241826 SCHEIN-AMOXICILLIN SCN
- 500mg Capsule
- 628123 APO-AMOXI APX
- 2238172 GEN-AMOXICILLIN GEN
- 2239762 MED-AMOXICILLIN MEC
- 406716 NOVAMOXIN NOP
- 865575 NU-AMOXI NXP
- 2233017 PENTA-AMOXICILLIN PEN
- 2230244 PMS-AMOXICILLIN PMS
- 644315 PRO-AMOX PDL
- 2241827 SCHEIN-AMOXICILLIN SCN
- 125mg Chewable Tablet
- 2036347 NOVAMOXIN NOP
- 250mg Chewable Tablet
- 2036355 NOVAMOXIN NOP
- 25mg/mL Suspension
- 628131 APO-AMOXI APX
- 452149 NOVAMOXIN NOP
- 1934171 NOVAMOXIN SUGAR REDUCED NOP
- 865540 NU-AMOXI NXP
- 2229582 PENTA-AMOXICILLIN PEN
- 2230245 PMS-AMOXICILLIN PMS
- 644323 PRO-AMOX PDL
- 50mg/mL Suspension
- 628158 APO-AMOXI APX
- 452130 NOVAMOXIN NOP
- 1934163 NOVAMOXIN SUGAR REDUCED NOP
- 865559 NU-AMOXI NXP
- 2229583 PENTA-AMOXICILLIN PEN
- 2230246 PMS-AMOXICILLIN PMS
- 644331 PRO-AMOX PDL
AMOXICILLIN, CLAVULANIC ACID
- 25mg & 6.25mg/mL Suspension
- 2243986 APO-AMOXI CLAV APX
- 1916882 CLAVULIN-F 125 GSK
- 40mg & 5.7mg/mL Suspension
- 2288559 APO-AMOXI CLAV APX
- 2238831 CLAVULIN 200 GSK
- 50mg & 12.5mg/mL Suspension
- 2243987 APO-AMOXI CLAV APX
- 1916874 CLAVULIN-F 250 GSK
AMOXICILLIN, CLAVULANIC ACID
- 80mg & 11.4mg/mL Suspension
- 2238830 CLAVULIN 400 GSK
- 250mg & 125mg Tablet
- 2243350 APO-AMOXI CLAV APX
- 500mg & 125mg Tablet
- 2243351 APO-AMOXI CLAV APX
- 1916858 CLAVULIN-F GSK
- 2243771 RATIO-ACLAVULANATE RPH
- 875mg & 125mg Tablet
- 2245623 APO-AMOXI CLAV APX
- 2238829 CLAVULIN GSK
- 2248138 NOVO-CLAVAMOXIN NOP
- 2247021 RATIO-ACLAVULANATE RPH
AMPICILLIN
- 250mg Capsule
- 20877 NOVO-AMPICILLIN NOP
- 500mg Capsule
- 20885 NOVO-AMPICILLIN NOP
- 25mg/mL Suspension
- 603260 APO-AMPICILLIN APX
- 717495 NU-AMPI NXP
- 50mg/mL Suspension
- 603287 APO-AMPICILLIN APX
- 717649 NU-AMPI NXP
- 2043203 PENBRITIN WAY
CLOXACILLIN
- 250mg Capsule
- 618292 APO-CLOXI APX
- 2069660 CLOXACILLINE PRO
- 337765 NOVO-CLOXIN NOP
- 717584 NU-CLOXI NXP
- 500mg Capsule
- 618284 APO-CLOXI APX
- 2069679 CLOXACILLINE PRO
- 337773 NOVO-CLOXIN NOP
- 717592 NU-CLOXI NXP
- 25mg/mL Suspension
- 644633 APO-CLOXI APX
- 337757 NOVO-CLOXIN NOP
- 717630 NU-CLOXI NXP
PENICILLIN V BENZATHINE
- 36mg/mL Suspension
- 2229618 PEN VEE PED
- 60mg/mL Suspension
- 2229617 PEN VEE PED
PENICILLIN V POTASSIUM
- 25mg/mL Suspension
- 642223 APO-PEN VK APX
- 60mg/mL Suspension
- 642231 APO-PEN VK APX
- 391603 NOVO-PEN VK NOP
PENICILLIN V POTASSIUM
- 300mg Tablet
- 642215 APO-PEN VK APX
- 21202 NOVO-PEN VK NOP
- 717568 NU-PEN VK NXP
- 468029 PENICILLINE V PDL
PIVMECILLINAM HCL
- 200mg Tablet
- 657212 SELEXID LEO
08:12.18 QUINOLONES
CIPROFLOXACIN HCL
- 250mg Tablet
- 2229521 APO-CIPROFLOX APX
- 2155958 CIPRO BAY
- 2251752 CIPROFLOXCIN PDL
- 2247339 CO CIPROFLOXACIN COB
- 2251272 DOM-CIPROFLOXACIN DPC
- 2245647 GEN-CIPROFLOXACIN GEN
- 2317427 MINT-CIPROFLOXACIN MIN
- 2161737 NOVO-CIPROFLOXACIN NOP
- 2249634 NU-CIPROFLOXACIN NXP
- 2251310 PHL-CIPROFLOXACIN PHH
- 2248437 PMS-CIPROFLOXACIN PMS
- 2249960 PREM-CIPROFLOXACIN PRE
- 2317796 PRO-CIPROFLOXACIN PDL
- 2303728 RAN-CIPROFLOX RBY
- 2267934 RAN-CIPROFLOXACIN RBY
- 2246825 RATIO-CIPROFLOXACIN RPH
- 2251221 RIVA-CIPROFLOXACIN RIV
- 2248756 SANDOZ-CIPROFLOXACIN SDZ
- 2266962 TARO-CIPROFLOXACIN TAR
- 500mg Tablet
- 2229522 APO-CIPROFLOX APX
- 2155966 CIPRO BAY
- 2251760 CIPROFLOXACIN PDL
- 2247340 CO CIPROFLOXACIN COB
- 2251280 DOM-CIPROFLOXACIN DPC
- 2245648 GEN-CIPROFLOXACIN GEN
- 2317435 MINT-CIPROFLOXACIN MIN
- 2161745 NOVO-CIPROFLOXACIN NOP
- 2249642 NU-CIPROFLOXACIN NXP
- 2251329 PHL-CIPROFLOXACIN PHH
- 2248438 PMS-CIPROFLOXACIN PMS
- 2249979 PREM-CIPROFLOXACIN PRE
- 2317818 PRO-CIPROFLOXACIN PDL
- 2303736 RAN-CIPROFLOX RBY
- 2267942 RAN-CIPROFLOXACIN RBY
- 2246826 RATIO-CIPROFLOXACIN RPH
- 2248757 RHOXAL-CIPROFLOXACIN RHO
- 2251248 RIVA-CIPROFLOXACIN RIV
- 2266970 TARO-CIPROFLOXACIN TAR
CIPROFLOXACIN HCL
- 750mg Tablet
- 2229523 APO-CIPROFLOX APX
- 2155974 CIPRO BAY
- 2251779 CIPROFLOXACIN PDL
- 2247341 CO CIPROFLOXACIN COB
- 2251299 DOM-CIPROFLOXACIN DPC
- 2245649 GEN-CIPROFLOXACIN GEN
- 2317443 MINT-CIPROFLOXACIN MIN
- 2161753 NOVO-CIPROFLOXACIN NOP
- 2249650 NU-CIPROFLOXACIN NXP
- 2251337 PHL-CIPROFLOXACIN PHH
- 2248439 PMS-CIPROFLOXACIN PMS
- 2249987 PREM-CIPROFLOXACIN PRE
- 2303744 RAN-CIPROFLOX RBY
- 2267950 RAN-CIPROFLOXACIN RBY
- 2246827 RATIO-CIPROFLOXACIN RPH
- 2248758 RHOXAL-CIPROFLOXACIN RHO
- 2251256 RIVA-CIPROFLOXACIN RIV
LEVOFLOXACIN
Limited use benefit (prior approval not required).
Coverage will be limited to a maximum of 14 days.
- 250mg Tablet
- 2284707 APO-LEVOFLOXACIN APX
- 2315424 CO-LEVOFLOXACIN CBT
- 2286920 DOM-LEVOFLOXACIN DOM
- 2313979 GEN-LEVOFLOXACIN GEN
- 2236841 LEVAQUIN JNO
- 2307200 LEVOFLOXACIN SOR
- 2248262 NOVO-LEVOFLOXACIN NOP
- 2286947 PHL-LEVOFLOXACIN PMI
- 2284677 PMS-LEVOFLOXACIN PMS
- 2298635 SANDOZ LEVOFLOXACIN SDZ
- 500mg Tablet
- 2284715 APO-LEVOFLOXACIN APX
- 2315432 CO-LEVOFLOXACIN CBT
- 2286939 DOM-LEVOFLOXACIN DOM
- 2313987 GEN-LEVOFLOXACIN GEN
- 2236842 LEVAQUIN JNO
- 2307219 LEVOFLOXACIN SOR
- 2248263 NOVO-LEVOFLOXACIN NOP
- 2286955 PHL-LEVOFLOXACIN PMI
- 2284685 PMS-LEVOFLOXACIN PMS
- 2298643 SANDOZ LEVOFLOXACIN SDZ
NORFLOXACIN
- 400mg Tablet
- 2229524 APO-NORFLOX APX
- 2269627 CO NORFLOXACIN COB
- 2237682 NOVO-NORFLOXACIN NOP
- 2239670 PDL-NORFLOXACINE PDL
- 2246596 PMS-NORFLOXACIN PMS
- 2241483 RIVA-NORFLOXACIN RIV
- 2301504 RIVA-NORFLOXACIN RIV
OFLOXACIN
- 200mg Tablet
- 2231529 APO-OFLOX APX
- 300mg Tablet
- 2231531 APO-OFLOX APX
- 2243475 NOVO-OFLOXACIN NOP
- 400mg Tablet
- 2231532 APO-OFLOX APX
08:12.20 SULFONAMIDES
SULFAMETHOXAZOLE
- 500mg Tablet
- 421480 APO-SULFAMETHOXAZOLE APX
SULFAMETHOXAZOLE, TRIMETHOPRIM
- 40mg & 8mg/mL Suspension
- 726540 NOVO-TRIMEL NOP
- 100mg & 20mg Tablet
- 445266 APO-SULFATRIM PED APX
- 400mg & 80mg Tablet
- 445274 APO-SULFATRIM APX
- 510637 NOVO-TRIMEL NOP
- 865710 NU-COTRIMOX NXP
- 512516 PROTRIN PDL
- 800mg & 160mg Tablet
- 445282 APO-SULFATRIM DS APX
- 510645 NOVO-TRIMEL DS NOP
- 865729 NU-COTRIMOX DS NXP
- 512524 PROTRIN DF PRO
SULFASALAZINE
- 500mg Enteric Coated Tablet
- 598488 PMS-SULFASALAZINE PMS
- 2064472 SALAZOPYRIN PFI
- 500mg Tablet
- 598461 PMS-SULFASALAZINE PMS
- 2064480 SALAZOPYRIN PFI
08:12.24 TETRACYCLINES
DOXYCYCLINE
- 100mg Capsule
- 740713 APO-DOXY APX
- 817120 DOXYCIN RIV
- 742562 DOXYCYCLINE PDL
- 725250 NOVO-DOXYLIN NOP
- 2044668 NU-DOXYCYCLINE NXP
- 2289539 PMS-DOXYCYCLINE PMS
- 2093103 RATIO-DOXYCYCLINE RPH
DOXYCYCLINE
- 100mg Tablet
- 874256 APO-DOXY APX
- 860751 DOXYCIN RIV
- 887064 DOXYTAB PDL
- 2158574 NOVO-DOXYLIN NOP
- 2044676 NU-DOXYCYCLINE NXP
- 2289466 PMS-DOXYCYCLINE PMS
- 2091232 RATIO-DOXYCYCLINE RPH
MINOCYCLINE HCL
Limited use benefit (prior approval required).
For:
- patients who cannot tolerate other tetracyclines.
- patients with severe widespread acne who have failed on tetracycline.
- 50mg Capsule
- 2084090 APO-MINOCYCLINE APX
- 2239667 DOM-MINOCYCLINE DPC
- 2237875 MED-MINOCYCLINE MEC
- 2173514 MINOCIN STI
- 2108143 NOVO-MINOCYCLINE NOP
- 2153394 PDL-MINOCYCLINE PDL
- 2239238 PMS-MINOCYCLINE PMS
- 2294419 PMS-MINOCYCLINE PMS
- 1914138 RATIO-MINOCYCLINE RPH
- 2242080 RIVA-MINOCYCLINE RIV
- 2237313 SANDOZ-MINOCYCLINE SDZ
- 100mg Capsule
- 2084104 APO-MINOCYCLINE APX
- 2239668 DOM-MINOCYCLINE DPC
- 2237876 MED-MINOCYCLINE MEC
- 2173506 MINOCIN STI
- 2239982 MINOCYCLINE IVX
- 2108151 NOVO-MINOCYCLINE NOP
- 2154366 PDL-MINOCYCLINE PDL
- 2294427 PMS-MINOCYCLINE PMS
- 2239239 PMS-MONOCYCLINE PMS
- 1914146 RATIO-MINOCYCLINE RPH
- 2242081 RIVA-MINOCYCLINE RIV
- 2237314 SANDOZ-MINOCYCLINE SDZ
TETRACYCLINE HCL
- 250mg Capsule
- 580929 APO-TETRA APX
- 156744 TETRACYCLINE PRO
- 250mg Tablet
- 717606 NU-TETRA NXP
08:12.28 MISCELLANEOUS ANTIBIOTICS
CLINDAMYCIN HCL
- 150mg Capsule
- 2245232 APO-CLINDAMYCIN APX
- 2248525 CLINDAMYCINE PDL
- 30570 DALACIN C PFI
- 2258331 GEN-CLINDAMYCIN GEN
- 2241709 NOVO-CLINDAMYCIN NOP
- 2242409 RIVA-CLINDAMYCIN RIV
- 300mg Capsule
- 2245233 APO-CLINDAMYCIN APX
- 2248526 CLINDAMYCINE PDL
- 2182866 DALACIN C PFI
- 2258358 GEN-CLINDAMYCIN GEN
- 2241710 NOVO-CLINDAMYCIN NOP
- 2242410 RIVA-CLINDAMYCIN RIV
CLINDAMYCIN PALMITATE HCL
- 15mg/mL Solution
- 225851 DALACIN C PFI
FUSIDATE SODIUM
- 250mg Tablet
- 1934252 FUCIDIN FC LEO
LINEZOLID
Limited use benefit (prior approval required).
Tablets:
For treatment of proven vancomycin-resistant enterococci (VRE) infections when other antibiotics are not available, and for the treatment of proven Methicillin-Resistant Staphylococcus aureus (MRSA) infections in patients who cannot tolerate or who had an idiosyncratic reaction with Vancomycin.
I.V. solution:
When linezolid cannot be administered orally in the above mentioned situations.
- 2mg/mL Injection
- 2243685 ZYVOXAM PFI
- 600mg Tablet
- 2243684 ZYVOXAM PFI
08:14.04 ALLYLAMINES
TERBINAFINE HCL
- 250mg Tablet
- 2239893 APO-TERBINAFINE APX
- 2254727 CO TERBINAFINE COB
- 2242503 GEN-TERBINAFINE GEN
- 2031116 LAMISIL NVR
- 2240346 NOVO-TERBINAFINE NOP
- 2248845 NU-TERBINAFINE NXP
- 2240807 PMS-TERBINAFINE PMS
- 2294273 PMS-TERBINAFINE PMS
- 2262924 RIVA-TERBINAFINE RIV
- 2262177 SANDOZ-TERBINAFINE SDZ
08:14.08 AZOLES
FLUCONAZOLE
- 150mg Capsule
- 2241895 APO-FLUCONAZOLE APX
- 2311690 CANESORAL BAY
- 2323419 CO FLUCONAZOLE CBT
- 2141442 DIFLUCAN PFI
- 2245697 GEN-FLUCONAZOLE GEN
- 2243645 NOVO-FLUCONAZOLE NOP
- 2246620 PMS-FLUCONAZOLE PMS
- 2282348 PMS-FLUCONAZOLE PMS
- 2310694 PRO-FLUCONAZOLE PDL
- 2255510 RIVA-FLUCONAZOLE RIV
- 10mg/mL Suspension
- 2024152 DIFLUCAN PFI
- 50mg Tablet
- 2237370 APO-FLUCONAZOLE APX
- 891800 DIFLUCAN PFI
- 2245292 GEN-FLUCONAZOLE GEN
- 2236978 NOVO-FLUCONAZOLE NOP
- 2245643 PMS-FLUCONAZOLE PMS
- 2249294 TARO-FLUCONAZOLE TAR
- 100mg Tablet
- 2237371 APO-FLUCONAZOLE APX
- 2281279 CO FLUCONAZOLE CBT
- 2245293 GEN-FLUCONAZOLE GEN
- 2236979 NOVO-FLUCONAZOLE NOP
- 2245644 PMS-FLUCONAZOLE PMS
- 2310686 PRO-FLUCONAZOLE PDL
- 2271516 RIVA-FLUCONAZOLE RIV
- 2249308 TAR0-FLUCONAZOLE TAR
ITRACONAZOLE
- 100mg Capsule
- 2047454 SPORANOX JNO
- 10mg/mL Solution
- 2231347 SPORANOX JNO
KETOCONAZOLE
- 200mg Tablet
- 2237235 APO-KETOCONAZOLE APX
- 2231061 NOVO-KETOCONAZOLE NOP
- 2122197 NU-KETOCON NXP
VORICONAZOLE
Limited use benefit (prior approval required).
For the treatment of:
- patients with invasive aspergillosis.
- culture proven invasive candidiasis with documented resistance to fluconazole.
- 50mg Tablet
- 2256460 VFEND PFI
- 200mg Tablet
- 2256479 VFEND PFI
08:14.28 POLYENES
NYSTATIN
- 100,000U/mL Suspension
- 2125145 DOM-NYSTATIN DPC
- 792667 PMS-NYSTATIN PMS
- 2194201 RATIO-NYSTATIN RPH
- 500,000U Tablet
- 2194198 RATIO-NYSTATIN RPH
08:16.04 ANTITUBERCULOSIS AGENTS
ETHAMBUTOL HCL
- 100mg Tablet
- 247960 ETIBI VAE
- 400mg Tablet
- 247979 ETIBI VAE
ISONIAZID
- 10mg/mL Syrup
- 265500 ISOTAMINE VAE
- 577812 PMS-ISONIAZID PMS
- 50mg Tablet
- 577782 PMS-ISONIAZID PMS
- 300mg Tablet
- 272655 ISOTAMINE VAE
- 577804 PMS-ISONIAZID PMS
PYRAZINAMIDE
- 500mg Tablet
- 618810 PMS-PYRAZINAMIDE PMS
- 283991 TEBRAZID VAE
RIFABUTIN
- 150mg Capsule
- 2063786 MYCOBUTIN PFI
RIFAMPIN
- 150mg Capsule
- 2091887 RIFADIN SAC
- 393444 ROFACT VAE
RIFAMPIN
- 300mg Capsule
- 2092808 RIFADIN SAC
- 210463 RIMACTANE NVR
- 343617 ROFACT VAE
08:18.04 ADAMANTANES
AMANTADINE HCL
- 100mg Capsule
- 2130963 DOM-AMANTADINE DPC
- 2139200 GEN-AMANTADINE GEN
- 2199289 MED-AMANTADINE MEC
- 1990403 PMS-AMANTADINE PMS
- 10mg/mL Syrup
- 2130971 DOM-AMANTADINE DPC
- 2022826 PMS-AMANTADINE PMS
- 1913999 SYMMETREL BMS
08:18.08 ANTIRETROVIRALS
ABACAVIR
- 20mg/mL Oral Liquid
- 2240358 ZIAGEN GSK
- 300mg Tablet
- 2240357 ZIAGEN GSK
ABACAVIR, LAMIVUDINE
- 600mg & 300mg Tablet
- 2269341 KIVEXA GSK
ABACAVIR, LAMIVUDINE, ZIDOVUDINE
- 300mg & 150mg & 300mg Tablet
- 2244757 TRIZIVIR GSK
ATAZANAVIR SULFATE
- 150mg Capsule
- 2248610 REYATAZ BMS
- 200mg Capsule
- 2248611 REYATAZ BMS
- 300mg Capsule
- 2294176 REYATAZ BMS
DARUNAVIR
Limited use benefit (prior approval required).
For the management of HIV in patients who failed or have experienced adverse events to three or more listed protease inhibitors.
- 300mg Tablet
- 2284057 PREZISTA JNO
- 400mg Tablet
- 2324016 PREZISTA JNO
- 600mg Tablet
- 2324024 PREZISTA JNO
DIDANOSINE
- 125mg Capsule
- 2244596 VIDEX EC BMS
DIDANOSINE
- 200mg Capsule
- 2244597 VIDEX EC BMS
- 250mg Capsule
- 2244598 VIDEX EC BMS
- 400mg Capsule
- 2244599 VIDEX EC BMS
EFAVIRENZ
- 50mg Capsule
- 2239886 SUSTIVA BMS
- 200mg Capsule
- 2239888 SUSTIVA BMS
- 600mg Tablet
- 2246045 SUSTIVA BMS
EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Limited use benefit (prior approval required).
For the treatment of HIV-1 infection adults where the virus is
susceptible to each of tenofovir, emtricitabine and efavirenz,
and:
- Atripla is used to replace existing therapy with its
component drugs, or
- the patient is treatment naïve, or
- the patient has established viral suppression but
requires antiretroviral therapy modification due to intolerance
or adverse effects.
Note: Criteria will be confirmed against medication history.
- 600mg & 200mg & 300mg Tablet
- 2300699 ATRIPLA BMS
EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Limited use benefit (prior approval required).
For the treatment of patients with HIV infection where the
virus is susceptible to both emtricitabine and tenofovir AND
where the triple-entity antiretroviral agent (tenofovir/
emtricitabine/efavirenz) is not indicated due to one of the
following:
- efavirenz resistance
- adverse effects secondary to efavirenz
- 200mg/300mg Tablet
- 2274906 TRUVADA GIL
ETRAVIRINE
Limited use benefit (prior approval required).
For use in combination with other antiretroviral agents for treatment-experienced patients with HIV-1 infection who:
- have failed prior antiretroviral therapy; and
- have HIV-1 strains resistant to multiple antiretroviral agents, including NNRTIs
- 100mg Tablet
- 2306778 INTELENCE JNO
FOSAMPRENAVIR CALCIUM
- 50mg/mL Oral Suspension
- 2261553 TELZIR GSK
- 700mg Tablet
- 2261545 TELZIR GSK
INDINAVIR SULFATE
- 200mg Capsule
- 2229161 CRIXIVAN FRS
- 400mg Capsule
- 2229196 CRIXIVAN FRS
LAMIVUDINE
- 10mg/mL Solution
- 2192691 3TC GSK
- 100mg Tablet
- 2239193 HEPTOVIR GSK
- 150mg Tablet
- 2192683 3TC GSK
- 300mg Tablet
- 2247825 3TC GSK
LAMIVUDINE, ZIDOVUDINE
- 150mg & 300mg Tablet
- 2239213 COMBIVIR GSK
LOPINAVIR, RITONAVIR
- 80mg & 20mg/mL Oral Solution
- 2243644 KALETRA ABB
- 100mg & 25mg Tablet
- 2312301 KALETRA ABB
- 200mg & 50mg Tablet
- 2285533 KALETRA ABB
MARAVIROC
Limited use benefit (prior approval required).
For the treatment of HIV-1 infection, given in combination with other antiretroviral agents, in patients who have:
- CR5 tropic viruses; and
- documented resistance to at least one agent from each
of the three major classes of antiretroviral agents
(nucleoside reverse transcriptase inhibitors, non-nucleoside
reverse transcriptase inhibitors, and protease inhibitors)
- 150mg Tablet
- 2299844 CELSENTRI VII
- 300mg Tablet
- 2299852 CELSENTRI VII
NELFINAVIR MESYLATE
- 50mg/g Powder for Suspension
- 2238618 VIRACEPT PFI
- 250mg Tablet
- 2238617 VIRACEPT PFI
- 625mg Tablet
- 2248761 VIRACEPT PFI
NEVIRAPINE
- 200mg Tablet
- 2238748 VIRAMUNE BOE
RALTEGRAVIR
Limited use benefit (prior approval required).
For the treatment of HIV infection in patients who are antiretroviral experienced and have virologic failure due to resistance to at least one agent from each of the three major classes of antiretroviral agents, nucleoside/tide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
- 400mg Tablet
- 2301881 ISENTRESS FRS
RITONAVIR
- 100mg Capsule
- 2241480 NORVIR SEC ABB
- 80mg/mL Liquid
- 2229145 NORVIR ABB
SAQUINAVIR MESYLATE
- 200mg Capsule
- 2216965 INVIRASE HLR
- 500mg Tablet
- 2279320 INVIRASE HLR
STAVUDINE
- 15mg Capsule
- 2216086 ZERIT BMS
- 20mg Capsule
- 2216094 ZERIT BMS
- 30mg Capsule
- 2216108 ZERIT BMS
- 40mg Capsule
- 2216116 ZERIT BMS
TENOFOVIR DISOPROXIL FUMARATE
Limited use benefit (prior approval required).
For the management of HIV disease in patients who have failed or have experienced adverse events to an alternative nucleoside reverse transcriptase inhibitor.
- 245mg Tablet
- 2247128 VIREAD GIL
TIPRANAVIR
Limited use benefit (prior approval required).
For the management of HIV disease in patients
- who have failed all currently listed protease inhibitors
- intolerant to all currently listed protease inhibitors
- 250mg Capsule
- 2273322 APTIVUS BOE
ZIDOVUDINE
- 100mg Capsule
- 1946323 APO-ZIDOVUDINE APX
- 1902660 RETROVIR GSK
- 10mg/mL Syrup
- 1902652 RETROVIR GSK
08:18.20 INTERFERONS
PEGINTERFERON ALFA-2A
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
- 180mcg/0.5mL Injection
- 2248077 PEGASYS HLR
- 180mcg/1mL Injection
- 2248078 PEGASYS HLR
PEGINTERFERON ALFA-2A, RIBAVIRIN
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
- 180mcg/0.5mL & 200mg Injection & Tablet
- 2253429 PEGASYS RBV HLR
- 180mcg/1mL & 200mg Injection & Tablet
- 2253410 PEGASYS RBV HLR
PEGINTERFERON ALFA-2B
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered.
- 74mcg/Vial Injection
- 2242966 UNITRON PEG SCH
- 118.4mcg/Vial Injection
- 2242967 UNITRON PEG SCH
- 177.6mcg/Vial Injection
- 2242968 UNITRON PEG SCH
- 222mcg/Vial Injection
- 2242969 UNITRON PEG SCH
PEGINTERFERON ALFA-2B, RIBAVIRIN
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
- 50mcg/0.5mL & 200mg Injection & Capsule
- 2246026 PEGETRON SCH
- 2254573 PEGETRON REDIPEN SCH
- 80mcg/0.5mL & 200mg Injection & Capsule
- 2246027 PEGETRON SCH
- 2254581 PEGETRON REDIPEN SCH
- 100mcg/0.5mL & 200mg Injection & Capsule
- 2246028 PEGETRON SCH
- 2254603 PEGETRON REDIPEN SCH
- 120mcg/0.5mL & 200mg Injection & Capsule
- 2246029 PEGETRON SCH
- 2254638 PEGETRON REDIPEN SCH
- 150mcg/0.5mL & 200mg Injection & Capsule
- 2246030 PEGETRON SCH
- 2254646 PEGETRON REDIPEN SCH
08:18.32 NUCLEOSIDES AND NUCLEOTIDES
ACYCLOVIR
- 40mg/mL Suspension
- 886157 ZOVIRAX GSK
- 200mg Tablet
- 2207621 APO-ACYCLOVIR APX
- 2242784 GEN-ACYCLOVIR GEN
- 2285959 NOVO-ACYCLOVIR NOP
- 2197405 NU-ACYCLOVIR NXP
- 2237541 PDL-ACYCLOVIR PDL
- 2078627 RATIO-ACYCLOVIR RPH
- 634506 ZOVIRAX GSK
- 400mg Tablet
- 2207648 APO-ACYCLOVIR APX
- 2242463 GEN-ACYCLOVIR GEN
- 2285967 NOVO-ACYCLOVIR NOP
- 2197413 NU-ACYCLOVIR NXP
- 2237542 PDL-ACYCLOVIR PDL
- 2078635 RATIO-ACYCLOVIR RPH
- 1911627 ZOVIRAX GSK
ACYCLOVIR
- 800mg Tablet
- 2207656 APO-ACYCLOVIR APX
- 2242464 GEN-ACYCLOVIR GEN
- 2285975 NOVO-ACYCLOVIR NOP
- 2197421 NU-ACYCLOVIR NXP
- 2237543 PDL-ACYCLOVIR PDL
- 2078651 RATIO-ACYCLOVIR RPH
- 1911635 ZOVIRAX GSK
ADEFOVIR DIPIVOXIL
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis B infection when used
in combination with lamivudine in patients who have
developed failure to lamivudine, as defined by an increase in
HBV DNA of = 1 log10 IU/mL above the nadir, measured on
two separate occasions within an interval of at least one
month, after the first three months of lamivudine therapy, and
when failure to lamivudine is not due to poor adherence to
- 10mg Tablet
- 2247823 HEPSERA GIL
ENTECAVIR
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis B infection in patients with cirrhosis documented on radiologic or histologic grounds and a HBV DNA concentration above 2000IU/mL.
- 0.5mg Tablet
- 2282224 BARACLUDE BMS
FAMCICLOVIR
- 125mg Tablet
- 2292025 APO-FAMCICLOVIR APX
- 2305682 CO FAMCICLOVIR COB
- 2229110 FAMVIR NVR
- 2278081 PMS-FAMCICLOVIR PMS
- 2278634 SANDOZ-FAMCICLOVIR SDZ
- 250mg Tablet
- 2292041 APO-FAMCICLOVIR APX
- 2305690 CO FAMCICLOVIR COB
- 2229129 FAMVIR NVR
- 2278103 PMS-FAMCICLOVIR PMS
- 2278642 SANDOZ-FAMCICLOVIR SDZ
- 500mg Tablet
- 2292068 APO-FAMCICLOVIR APX
- 2305704 CO FAMCICLOVIR COB
- 2177102 FAMVIR NVR
- 2278111 PMS-FAMCICLOVIR PMS
- 2278650 SANDOZ-FAMCICLOVIR SDZ
GANCICLOVIR SODIUM
- 500mg Injection
- 2162695 CYTOVENE HLR
VALACYCLOVIR HCL
- 500mg Tablet
- 2295822 APO-VALACYCLOVIR APX
- 2298457 PMS-VALACYCLOVIR PMS
- 2316447 RIVA-VALACYCLOVIR RIV
- 2219492 VALTREX GSK
- 500mg Tablet
- 2315173 PRO-VALACYCLOVIR PDL
VALGANCICLOVIR HCL
- 450mg Tablet
- 2245777 VALCYTE HLR
08:30.04 AMEBICIDES
DIIODOHYDROXYQUIN
- 210mg Tablet
- 1997769 DIODOQUIN GLE
- 650mg Tablet
- 1997750 DIODOQUIN GLE
PAROMOMYCIN SULFATE
- 250mg Capsule
- 2078759 HUMATIN ERF
08:30.08 ANTIMALARIALS
CHLOROQUINE PHOSPHATE
- 250mg Tablet
- 21261 NOVO-CHLOROQUINE NOP
HYDROXYCHLOROQUINE SULFATE
- 200mg Tablet
- 2246691 APO-HYDROXYQUINE APX
- 2252600 GEN-HYDROXYCHLOROQUINE GEN
- 2017709 PLAQUENIL SAC
- 2311011 PRO-HYDROXYQUINE PDL
PRIMAQUINE PHOSPHATE
- 26.3mg Tablet
- 2017776 PRIMAQUINE SAC
PYRIMETHAMINE
- 25mg Tablet
- 4774 DARAPRIM GSK
08:30.92 MISCELLANEOUS ANTIPROTOZOALS
ATOVAQUONE
- 150mg/mL Suspension
- 2217422 MEPRON GSK
METRONIDAZOLE
- 500mg Capsule
- 2248562 APO-METRONIDAZOLE APX
- 250mg Tablet
- 545066 APO-METRONIDAZOLE APX
- 420409 METRONIDAZOLE PDL
PENTAMIDINE ISETHIONATE
- 300mg/Vial Injection
- 2183080 PENTAMIDINE MAY
08:36.00 URINARY ANTI-INFECTIVES
NITROFURANTOIN
- 50mg Capsule
- 1997637 MACRODANTIN PGP
- 2231015 NOVO-FURANTOIN NOP
- 100mg Capsule
- 2063662 MACROBID PGP
- 2231016 NOVO-FURANTOIN NOP
- 50mg Tablet
- 319511 APO-NITROFURANTOIN APX
- 100mg Tablet
- 312738 APO-NITROFURANTOIN APX
TRIMETHOPRIM
- 100mg Tablet
- 2243116 APO-TRIMETHOPRIM APX
- 200mg Tablet
- 2243117 APO-TRIMETHOPRIM APX